Restless legs syndrome: treatment with dopaminergic agents

Neurology
Cynthia L Comella

Abstract

Restless legs syndrome (RLS) is a common neurologic disorder that affects 5 to 10% of the population and increases in prevalence with aging. The clinical hallmarks of RLS include dysesthesias or paresthesias in the legs and sometimes the arms, occurring primarily at rest, which are usually worse in the evening and are alleviated by movement. RLS can be a disabling disorder, causing sleep disturbance at night and excessive sleepiness during the day. Although treatment with levodopa alleviates symptoms, many RLS patients develop rebound (occurrence of symptoms during the night) or augmentation (occurrence of symptoms before levodopa dosing in the evening). Augmentation occurs in up to 82% of patients treated with levodopa, limiting the long-term usefulness of this agent. The direct dopamine receptor agonists are long-acting drugs often administered as a single dose at bedtime. Among these agents, pergolide, pramipexole, ropinirole, and cabergoline have all been shown to alleviate RLS symptoms in 70 to 100% of patients. The most common adverse effect is nausea. Augmentation, although it may be associated with chronic agonist use, is usually mild and responsive to additional dosing. The direct dopamine receptor agonists have largel...Continue Reading

Citations

Jul 17, 2010·Journal of Neurology·Vincenzo RizzoA Quartarone
Mar 3, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Luca OstacoliAlfredo Berruti
Mar 27, 2004·Current Treatment Options in Neurology·Suzanne Lesage, Christopher J. Earley
Jan 17, 2004·Sleep Medicine·Diego Garcia-Borreguero
Nov 1, 2003·Sleep Medicine·Karel SonkaKarel Kranda
Dec 13, 2005·Clinical Neuropharmacology·Sung-Wan KimJin-Sang Yoon
Dec 20, 2007·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·A Gorsler, J Liepert
Nov 16, 2006·Journal of General Internal Medicine·Roger KurlanCheryl Deeley
May 9, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Norman WolkoveMark Palayew
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Gulcin Benbir, Christian Guilleminault
May 20, 2008·CNS Drugs·Pankaj Satija, William G Ondo
Mar 17, 2012·Clinical Neuropharmacology·Gulsen Babacan-YildizArif Celebi
Jun 3, 2006·Pediatrics in Review·Kevin TurnerDiana Dunnigan
May 7, 2008·Expert Review of Neurotherapeutics·Patrick B Wood
Jul 20, 2012·Expert Opinion on Drug Metabolism & Toxicology·Stefano de BiaseGian Luigi Gigli
Aug 26, 2014·Expert Opinion on Drug Metabolism & Toxicology·Stefano de BiaseGian Luigi Gigli
May 16, 2007·Expert Opinion on Investigational Drugs·Patrick B WoodKim D Jones
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Karin Stiasny-KolsterUNKNOWN Rotigotine Sp 666 Study Group
Mar 23, 2010·General Hospital Psychiatry·Young-Min ParkLeen Kim
May 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Alex IranzoWolfgang Oertel
Oct 4, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Roberto VetrugnoPasquale Montagna
Oct 11, 2005·Joint, Bone, Spine : Revue Du Rhumatisme·Pascale Vergne-SalleRichard Trèves
Mar 11, 2004·Pediatric Clinics of North America·Rafael PelayoChristian Guilleminault
Sep 4, 2015·Sleep Medicine Clinics·Nadir Askenasy, Jean-Jacques Askenasy
Sep 20, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Don Hayes
Mar 22, 2014·Journal of Korean Neurosurgical Society·Jin Seo YangHyuk Jai Choi
Oct 18, 2016·Sleep Medicine·Giuseppe LanzaWalter Paulus
Nov 3, 2016·Frontiers in Human Neuroscience·Xue Qing YangPenny A MacDonald
Apr 20, 2007·Journal of Oral Rehabilitation·J Van der ZaagM Naeije
Feb 6, 2009·The Annals of Pharmacotherapy·Jennifer J LeeBrenda Wagoner
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C Trenkwalder
Apr 22, 2008·British Journal of Hospital Medicine·Nigel Hyman
Jun 4, 2015·Movement Disorders Clinical Practice·Maria-Lucia MunteanClaudia Trenkwalder
Mar 31, 2018·Frontiers in Neurology·Ulrike H MitchellScott C Steffensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.